Looking for a job

Daniele Curtale

@danielecurtale

Senior Marketing Manager at Novo Nordisk who shaped regional portfolio strategy and led Ozempic® launch planning across five LATAM countries.

Uganda

Message

At Novo Nordisk, I led regional portfolio and brand strategy across LATAM and BASAC, including loss-of-exclusivity planning and reimbursement strategy for injectable GLP-1s. In Brazil, I led the Ozempic® launch activity plan across five LATAM countries, contributing to 48% sales growth in the first full year.

Earlier at Novo Nordisk, I developed global market access strategies and launch tools, including a Wegovy® weight-loss benefit simulation model adopted by more than 20 affiliates. I also founded Sanugit (U) Ltd. and led the launch of its Hygienio® surgical infection control system.

Experience

Work history, roles, and key accomplishments

Senior Marketing Manager - Cardiometabolic Portfolio

Novo Nordisk Panamá, S.A.

Jan 2026 - Sep 2026 (8 months)

Led BASAC Loss of Exclusivity strategy across 3 affiliates and 2 clusters, delivering 5 business cases and driving regional Brand Plan 2027. Managed a portfolio accounting for 90% of total regional revenue.

Portfolio Strategy LOE Brand Plans Market Access P&L management Cross functional Leadership Event Management

Senior Marketing Manager - Diabetes Portfolio

Novo Nordisk Farmacêutica do Brasil Ltda.

Jan 2025 - Dec 2025 (11 months)

Led Ozempic launch across 5 LATAM countries, driving 48% sales growth, and managed portfolio consolidation for insulin and GLP-1 brands. Co-created cardiology engagement strategy and delivered cross-functional training.

Launch Excellence Portfolio Management Market Research Customer Segmentation Training GLP 1 Insulin

Business Development Manager - Cardiovascular Disease (CVD) Portfolio

Novo Nordisk Farmacêutica do Brasil Ltda.

Oct 2023 - Dec 2024 (1 year 2 months)

Built commercial opportunity assessments for pipeline products, unlocking $1.8M in launch readiness funding. Authored first endorsed LATAM CVD and Cardio-Kidney-Metabolic brand strategy and delivered 5 market research reports.

Business Case Development Market Research Go To Market Strategy Governance Prioritization

Market Access & Commercial Manager – New Therapeutic Areas

Novo Nordisk Farmacêutica do Brasil Ltda.

Sep 2022 - Oct 2023 (1 year 1 month)

Led LATAM organisational readiness for expansion into MASH, Alzheimer's disease and CVD, securing $1.2M in budgets and 7 FTEs. Executed 15 primary market research studies to guide strategic decisions.

Market Access Market Research Strategic Planning Budget Management Capacity Building

Global Market Access Graduate Program (3 rotations)

Novo Nordisk A/S

Sep 2020 - Sep 2022 (2 years)

Developed payer value propositions and global access strategies for early CVD portfolio, co-developed global Wegovy access strategy, and managed obesity launch team budget. Built access database cutting insight generation time by 67%.

Market Access Payer Value Payer Advisory Boards KOL Interviewing Budget Management Simulation Modeling Dossier Platform

Market Access Specialist

AbbVie S.L.U.

Jun 2019 - Jan 2020 (7 months)

Supported CLL dossier submission for second-line indication, contributed to budget impact and cost-effectiveness analyses, and managed competitor access and pricing database.

Market Access Dossier Submission Budget Impact Analyses Cost Effectiveness Analysis Competitive Analysis

Founder & General Manager

Sanugit (U) Ltd.

May 2015 - Sep 2018 (3 years 4 months)

Founded and ran a MedTech distribution company, securing hospital contracts and government tenders. Led launch of Hygienio surgical infection control system and scaled company to $145K valuation with 24% annual revenue growth.

entrepreneurship Business Development Contract Negotiation Government Tenders Product Launch Revenue Growth